Difficulty: Medium
Average Score: 64%
Practice
Monthly injections of palivizumab, a RSV-specific monoclonal antibody, initiated just before the onset of the RSV season confers some protection from severe RSV disease. Palivizumab is indicated for some infants under 2 years old with
Correct answer
B
Rationale
Failed to generate a rationale of 500+ characters after 5 retries.